Home » Topics » BioWorld Science

BioWorld Science
RSS

Extension study results of patisiran in transthyretin-related amyloid polyneuropathy presented

Jan. 8, 2021

ApoE multitasks for regulating brain lipids

Jan. 8, 2021

Sanofi selects NK cell engager IPH-6101 as drug candidate

Jan. 8, 2021

Cerecor reports phase II proof-of-concept data for CERC-002 in COVID-19 ARDS

Jan. 7, 2021

Phase III ultraVIOLET study of oteseconazole for recurrent VVC meets endpoints

Jan. 7, 2021

Inovio reports phase II data on VGX-3100 to treat HPV-16- and -18-associated vulvar dysplasia

Jan. 7, 2021

FDA allows Cure's IND for CUREfilm Blue

Jan. 7, 2021

Treatment begins in phase I/IIa trial of AXT-107 in DME

Jan. 7, 2021

Chemomab reports phase Ib data on CM-101 in patients with NAFLD

Jan. 7, 2021

FDA lifts partial clinical hold on Marker's phase II trial of MT-401 for AML

Jan. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...